AIM
XENE icon

AXA Investment Managers’s Xenon Pharmaceuticals XENE Stock Holding History

AXA Investment Managers’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.07M Buy
+176,157
New +$6.2M 0.02% 489

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

AXA Investment Managers's XENE Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2025: 176,157 shares worth $7.07M. The stake represents 0.02% of the portfolio and ranks #489 among its holdings.

219 funds tracked by Wall St. Rank hold XENE as of Q3 2025.

  • AXA Investment Managers held 176,157 shares of Xenon Pharmaceuticals worth $7.07M as of Q3 2025.
  • Xenon Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
  • Xenon Pharmaceuticals made up 0.02% of AXA Investment Managers's portfolio in Q3 2025, its #489 holding.
  • 219 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.